Group One Trading
CRDF icon

Group One Trading’s Cardiff Oncology CRDF Stock Holding History

Group One Trading’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,175
Closed -$40K – 7712
2026
Q1 		$40.8K Sell
25,175
-16,699
-40% -$34.3K ﹤0.01% 5418
2025
Q4 		$118K Buy
+41,874
New +$97.2K ﹤0.01% 4860
2025
Q3 		– Sell
-2,863
Closed -$7.91K – 8508
2025
Q2 		$9.02K Buy
2,863
+1,990
+228% +$6.07K ﹤0.01% 6785
2025
Q1 		$2.74K Sell
873
-10,563
-92% -$41.8K ﹤0.01% 6891
2024
Q4 		$49.6K Sell
11,436
-30,158
-73% -$94.3K ﹤0.01% 5061
2024
Q3 		$111K Buy
41,594
+6,818
+20% +$16.1K ﹤0.01% 4090
2024
Q2 		$77.2K Buy
34,776
+24,642
+243% +$92.9K ﹤0.01% 4161
2024
Q1 		$54.1K Sell
10,134
-2,243
-18% -$5.96K ﹤0.01% 4655
2023
Q4 		$18.3K Sell
12,377
-21,827
-64% -$26.4K ﹤0.01% 5810
2023
Q3 		$47.5K Buy
34,204
+6,228
+22% +$10.5K ﹤0.01% 5142
2023
Q2 		$41.1K Buy
27,976
+5,842
+26% +$9.42K ﹤0.01% 5423
2023
Q1 		$36.5K Buy
+22,134
New +$38K ﹤0.01% 5083
2022
Q4 		– Sell
-4,619
Closed -$6.62K – 7344
2022
Q3 		$7K Sell
4,619
-31,850
-87% -$76.7K ﹤0.01% 6689
2022
Q2 		$80K Sell
36,469
-7,085
-16% -$11.9K ﹤0.01% 5182
2022
Q1 		$108K Buy
43,554
+4,903
+13% +$17.3K ﹤0.01% 5414
2021
Q4 		$232K Sell
38,651
-33,668
-47% -$201K ﹤0.01% 4934
2021
Q3 		$482K Buy
72,319
+62,696
+652% +$394K ﹤0.01% 4228
2021
Q2 		$64K Buy
+9,623
New +$81.6K ﹤0.01% 6359

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Group One Trading's CRDF Position: Q2 2026 in Review

Group One Trading sold out of Cardiff Oncology (CRDF) in Q2 2026, closing a stake of 25,175 shares — an estimated $40K sold.

Group One Trading first reported a position in CRDF in Q2 2021 and held it in 18 quarters. The position peaked at $482K in Q3 2021. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Group One Trading reported no remaining Cardiff Oncology position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 25,175 Cardiff Oncology shares in Q2 2026, an estimated $40K.
  • Group One Trading first reported a position in Cardiff Oncology in Q2 2021 and held it in 18 quarters.
  • Group One Trading's Cardiff Oncology position peaked at $482K in Q3 2021.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.